🇺🇸 FDA
Patent

US 8445245

Mutant MT-SP1 proteases with altered substrate specificity or activity

granted A61PA61P27/02A61P29/00

Quick answer

US patent 8445245 (Mutant MT-SP1 proteases with altered substrate specificity or activity) held by Catalyst Biosciences, Inc. expires Mon May 16 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Catalyst Biosciences, Inc.
Grant date
Tue May 21 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 16 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61P, A61P27/02, A61P29/00, A61P3/10, A61P31/00